Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/18/26
Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher24/7 Wall Street • 09/17/26
Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID?Zacks Investment Research • 09/15/26
Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Moderna's COVID Vaccine Was a Historic Success. Could Its Cancer Vaccine Be Even Bigger?The Motley Fool • 09/14/26
How Cathie Wood's Fund Gave Us A Back Door To Moderna's BreakthroughInvestors Business Daily • 09/11/26
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat24/7 Wall Street • 09/11/26
Congresswoman Bets on Elon Musk, Warren Buffett: Here's the Latest Stock TransactionsBenzinga • 09/10/26
If You'd Invested in Moderna (MRNA) Stock 5 Years Ago, Here's How Much You'd Have Today (Hint: You'd Be Disappointed -- But Not If You Bought It 1 Year Ago.)The Motley Fool • 09/06/26
Two scientists made huge bets on 'impossible' cancer treatments. They're finally paying off.Business Insider • 09/05/26
Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?The Motley Fool • 09/04/26